Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Khaled Kebaish

Orthopaedic Surgery Baltimore, MD Medical Doctor

NPI 1487618302 CMS profile 66459

600 N Wolfe St, Baltimore, MD 21287

Open in the dashboard

General payments

$3,048,038

251 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$63,616

5 holdings reported · through program year 2025

Research they led as principal investigator

$427,649 paid to institutions, not to them · program year 2019

Through program year 2025, Khaled Kebaish of Baltimore, MD is reported in the CMS Open Payments database as having received $3,048,038 across 251 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $427,649 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $63,616 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $406,545 28
2024 General $614,027 25
2023 General $149,276 25
2022 General $335,555 32
2021 General $447,137 37
2020 General $564,070 26
2019 General $531,429 78
2023 Ownership $17,616 1
2022 Ownership $4,000 1
2021 Ownership $14,000 1
2020 Ownership $14,000 1
2019 Ownership $14,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Khaled Kebaish
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Khaled Kebaish were reported at $406,545. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Khaled Kebaish Orthopaedic Surgery median Middle half National median
2019 $531,429 $644 $140–$2,844 $163
2020 $564,070 $312 $75–$1,860 $114
2021 $447,137 $520 $117–$2,495 $132
2022 $335,555 $598 $128–$2,731 $149
2023 $149,276 $461 $128–$2,264 $160
2024 $614,027 $497 $134–$2,475 $164
2025 $406,545 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $1,431,288 23 payments
  2. DePuy Synthes Products, Inc. $794,607 86 payments
  3. Orthofix Medical, Inc. $336,882 37 payments
  4. VB Spine LLC $197,190 3 payments
  5. Medical Device Business Services, Inc. $115,999 58 payments
  6. Zimmer Biomet Holdings, Inc. $78,451 1 payment
  7. SpineCraft, LLC $66,679 12 payments
  8. Ethicon Inc. $17,010 9 payments
  9. Ethicon US, LLC $5,400 3 payments
  10. NuVasive, Inc. $3,846 13 payments
  11. Other $686 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,712,142 67 payments
  2. Consulting Fee $236,566 61 payments
  3. Acquisitions $78,451 1 payment
  4. Travel and Lodging $17,043 52 payments
  5. Food and Beverage $3,837 70 payments
Products named General payments · program years 2019–2025
  1. YUKON OCT SPINAL SYSTEM Spine $1,144,470 13 payments
  2. VIPER Spine $627,155 11 payments
  3. YUKON $282,951 7 payments
  4. YUKON OCT SPINAL SYSTEM Spine $197,190 3 payments
  5. FIREBIRD NXG $180,383 16 payments
  6. VIPER Spine $95,368 3 payments
  7. Firebird NXG Spinal Fixation System $87,509 9 payments
  8. ArchiMIS $78,451 1 payment
  9. TRIALTIS $68,453 4 payments
  10. ASTRA Spine System $66,679 12 payments
  11. Other $326,635 151 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$241,520

Medicare's payments for the services billed

Medicare patients

294

Average age 73

Services billed

921

188 women, 106 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Osteoporosis 44%
Ischemic heart disease 32%
Diabetes 28%
Depression 27%
Chronic kidney disease 19%
Atrial fibrillation 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

251 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record